April is Oesophageal Cancer Awareness Month.

Chris Capstick

Oesophageal Cancer is considered a rare cancer with low survival rates and little recognition. Raising funds and awareness for Oesophageal cancer helps

PBAC recommends subsidised therapies for biliary and oesophageal cancers

Nikki Rynia

The Pharmaceutical Benefits Advisory Committee (PBAC) last week announced two positive recommendations for therapies that will benefit biliary and oesophageal cancer patients. The therapies brought

New PBAC application supports immunotherapy treatment for oesophageal and gastro-oesophageal junction cancers

Nikki Rynia

Pancare is supporting Bristol Meyers Squibb in their application to the Pharmaceutical Benefits Advisory Committee (PBAC) for the funding of Nivolumab, an immunotherapy for the treatment of

Advocating for upper GI cancers: oesophageal and gastric cancer update

Nikki Rynia

An important part of Pancare supporting patients with upper gastrointestinal (GI) cancers is advocating for better treatment and unmet needs.